Join SIO for the second annual NEXT Summit: Novel Explorations in Combination Therapies, taking place 28–29 May 2026 at the Gleacher Center in Chicago.

Experience a one-of-a-kind educational program that delivers cutting-edge, clinically integrated insights, spotlighting the latest advances in combination therapies and an expanded range of organ-specific content. Designed in collaboration with SITC and AASLD, the NEXT Summit offers a dynamic, multidisciplinary environment where attendees can explore breakthrough therapeutic innovations and emerging immunotherapy strategies.

The 2026 NEXT Summit program broadens its focus beyond HCC and liver cancers to include additional disease states, integrating novel therapeutic applications and next-generation combination approaches that reflect the rapidly evolving landscape of patient care and drive forward-thinking treatment strategies.

Register Today

Learning Objectives

• Critically evaluate landmark clinical trial data from 2025–2026 and translate these findings into forward-looking strategies that shape patient care.
• Apply emerging evidence in combination and sequencing approaches to optimize IO and systemic treatment regimens across disease stages.
• Integrate clinical factors and case-based decision-making to deliver Y-90 radioembolization safely and effectively in complex hepatocellular carcinoma, including high lung shunt fractions, macrovascular invasion, large tumors, and multifocal disease.
• Evaluate emerging intratumoral agents and the role in combination immunotherapy strategies for real-world implementation of new therapeutic approaches.
• Identify where innovations in devices, imaging, and AI for interventional oncology add procedural enhancements.
• Assess the future-facing strategies, and approaches using precision medicine for patient-centered care.

 

Thank You to Our Next Summit Sponsors